Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A4 | Q9H015 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | ALPL | P05186 | 1/20 | 0.46 |
| ▸ | ALPG | P10696 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29418359 | 0.82 | SLC22A4 (0.52) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL188140 | 0.82 | SLC22A4 (0.52) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL2954946 | 0.82 | SLC22A4 (0.52) | SLC22A4POLBALPLALPGGAA | |
| Water SCHEMBL7254213 | 0.81 | SLC22A4 (0.51) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL29705505 | 0.81 | SLC22A4 (0.51) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL29601603 | 0.81 | SLC22A4 (0.51) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL26315497 | 0.73 | SLC22A4 (0.55) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL1331027 | 0.73 | SLC22A4 (0.55) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL29514561 | 0.72 | SLC22A4 (0.43) | SLC22A4POLBALPLALPGGAA | |
| SCHEMBL29581787 | 0.72 | SLC22A4 (0.42) | SLC22A4POLBALPLALPGGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9753018-B2 | Selenium-containing compound | FISHERIES RESEARCH AGENCY (JP) | 2017-09-05 | — | — | US | disclosed |
| US-20160266079-A1 | NOVEL SELENIUM-CONTAINING COMPOUND | FISHERIES RESEARCH AGENCY (JP) | 2016-09-15 | — | — | US | disclosed |
| US-9393231-B2 | Selenium-containing compound | FISHERIES RESEARCH AGENCY (JP) | 2016-07-19 | — | — | US | disclosed |
| US-20150297569-A1 | NOVEL SELENIUM-CONTAINING COMPOUND | FISHERIES RESEARCH AGENCY (JP) | 2015-10-22 | — | — | US | disclosed |
| US-9109158-B2 | Selenium-containing compounds | FISHERIES RESEARCH AGENCY (JP) | 2015-08-18 | — | — | US | disclosed |
| US-20110178018-A1 | NOVEL SELENIUM-CONTAINING COMPOUNDS | FISHERIES RESEARCH AGENCY (JP) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178018-A1 | NOVEL SELENIUM-CONTAINING COMPOUNDS | GPX4, GPX1, SELENOI | SLC22A4 341/4885POLB 841/4885ALPL 2374/4885 |
| US-20150297569-A1 | NOVEL SELENIUM-CONTAINING COMPOUND | GPX1, GPX4, SELENOI | SLC22A4 643/4885POLB 1337/4885ALPL 2826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.